CDNA Competitors & Alternatives
Compare CareDx Inc with similar stocks in the same industry
Diagnostics & Research
CDNA
Main Stock$50.26
Tradestie Score
37
Market Cap
$798.40M
P/E Ratio
24.2
Revenue Growth
0.5%
Analyst Upside
+7.7%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$85.27
|
$3.26B | - | 36 | Compare |
|
VCYT
Veracyte, Inc.
|
$40.87
|
$2.85B | 31.3 | 52 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$76.23
|
$2.24B | - | 49 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$24.20
|
$2.22B | - | 55 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$127.22
|
$1.77B | - | 46 | Compare |
|
NEOG
Neogen Corp
|
$11.78
|
$1.26B | - | 46 | Compare |
|
OPK
Opko Health Inc.
|
$1.57
|
$1.23B | - | 43 | Compare |
|
NEO
NeoGenomics, Inc.
|
$17.32
|
$1.13B | - | 43 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$20.45
|
$719.31M | - | 48 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$32.33
|
$667.77M | - | 42 | Compare |
More CDNA Analysis
Data updated: Sep 11, 2026 | Industry: Diagnostics & Research (SIC 8071)
35 stocks in this industry